Quantitative Perfusion
Caitlin E.M Vink, MD
MD
Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands
Caitlin E.M Vink, MD
MD
Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands
Sonia borodzicz_Jazdyzk, MD
MD
Amsterdam University Medical Centers- Location VUmc, Netherlands
Roel Hoek, MD
MD
Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands, Netherlands
Mitchel Benovoy, PhD
PhD
Area19 Medical Inc, Montreal, Canada, H2V 2X5
Montreal, Quebec, Canada
Yolande Appelman, MD, PhD
Interventional Cardiologist
VU University Medical Center
Amsterdam, Noord-Holland, Netherlands
Marco J. Götte, MD, PhD
MD, PhD
Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands
Quantitative perfusion cardiovascular magnetic resonance (QP CMR) enables absolute assessment of myocardial blood flow (MBF), by acquisition of signal-intensity curves of first pass gadolinium-based contrast agent (GBCA) and tracer kinetic analysis. However precise MBF quantification is influenced by a nonlinear relationship between the obtained signal intensity and GBCA concentration. Dual-bolus first-pass perfusion CMR uses the combination of both low and high GBCA concentration to achieve the required linearity of signal intensity allowing for accurate MBF measurement. A general concern is the signal-to-noise ratio since this effects the QP analysis. Hereby we propose an optimized dual-bolus scanning protocol using an adjusted contrast-administration scheme to enhance the signal-to-noise ratio without associated contrast-induced artefacts.
Methods:
Adenosine stress perfusion CMR imaging at 3T was performed in subjects with 3 different medical conditions. The analysis included QP CMR was performed in 3 patients with obstructive coronary artery disease (CAD) as confirmed by invasive coronary angiogram, 3 patients with invasively diagnosed microvascular dysfunction (MVD) and 3 healthy controls. Myocardial perfusion images were acquired using a gradient-recalled echo acquisition at basal, mid and apical level.
Stress images were acquired using a saturation recovery turbo spoiled gradient echo sequence after at least 3 minutes of constant intravenous infusion of adenosine (140 μg/kg/min). Rest images were acquired at least 10 minutes after adenosine infusion. The arterial input function (AIF) images were acquired during intravenous administration of a pre-bolus of GBCA (DOTAREM®, Guerbet, Villepinte, France 0.5 mmol/ml) at a dose of 0.0075 mmol/kg 3ml/sec. Perfusion images were acquired using a main bolus of GBCA at a dose of 0.075 mmol/kg 3ml/sec. (Figure 1). The images were analysed offline using cvi42 software (Circle Cardiovascular Imaging Inc, Calgary, Canada) equipped with a fully automated pixel-wise QP CMR module.
Results: The proposed scanning protocol provided high quality images, with a high signal-to-noise ratio, which could be post-processed by the fully automated QP-framework. Assessment of pixel-wise stress MBF maps enabled diagnosis of ischemia in patients with obstructive CAD and MVD. No perfusion defect was visible on pixel-wise stress MBF maps in a healthy control patient (Figure 2).
Conclusion: The optimized dual-bolus scanning protocol seems to achieve a good linearity of signal intensity, resulting in high quality images suitable for QP post-processing without hampering of the signal-to-noise-ratio. This might improve the applicability of QP in diagnosing ischemia in patients with obstructive CAD and MVD.